HIV-1 Virulence Stable in North America
Author Information
Author(s): Joshua T. Herbeck, Geoffrey S. Gottlieb, Xiuhong Li, Zheng Hu, Roger Detels, John Phair, Charles Rinaldo, Lisa P. Jacobson, Joseph B. Margolick, James I. Mullins
Primary Institution: University of Washington School of Medicine
Hypothesis
Has HIV-1 virulence changed over time in North America?
Conclusion
The study found no significant changes in HIV-1 virulence over the AIDS pandemic in men who have sex with men in the US.
Supporting Evidence
- No significant trends were found in plasma viral load or CD4 cell count over the study period.
- Prognostic markers used in the study included plasma viral RNA load and CD4+ T cell count.
- Data was collected from the Multicenter AIDS Cohort Study (MACS) involving men who have sex with men.
Takeaway
The researchers looked at how HIV-1 affects people over time and found that it hasn't become more or less harmful in North America.
Methodology
The study analyzed trends in clinical markers of disease progression among nearly 400 antiretroviral-naïve participants from 1984 to 2005.
Potential Biases
Possible selection bias due to exclusion of men who started antiretroviral therapy.
Limitations
The study could not use clinical AIDS endpoints due to the impact of antiretroviral therapies, and there may be selection bias as men who progressed to disease were excluded.
Participant Demographics
Participants were predominantly men who have sex with men, with a median age at seroconversion of 30-39 years.
Statistical Information
P-Value
p=0.76
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website